Progress on vitamin D in the preventionand treatment of colorectal cancer and its supplementation applications

doi:10.16352/j.issn.1001-6325.2025.03.0404

Abstract

Abstract: Colorectal cancer is one of the common malignant tumors in digestive system, because of its incidence and mortality rates rising annually in China, seriously threating to people′s lives and health. Vitamin D plays an important role in inhibiting colorectal cancer by suppressing tumor cell proliferation, promoting tumor cell apoptosis, inhibiting tumor cell migration, invasion, and angiogenesis and also, enhancing the body′s immune system. This article summarizes and analyzes the specific mechanisms by which vitamin D inhibits the occurrence and development of colorectal cancer, and discusses the current progress in research on vitamin D supplementation, providing new references for the early prevention and adjuvant treatment of colorectal cancer.

Key words: vitamin D, colorectal cancer, dosage of vitamin D

CLC Number:

R453.3

ZHANG Shujun, LI Tiantian, ZHONG Mingliang, ZHANG Jian, DONG Xinmin. Progress on vitamin D in the preventionand treatment of colorectal cancer and its supplementation applications[J]. Basic & Clinical Medicine, 2025, 45(3): 404-408.

References

[1] Hernández-Alonso P, Boughanem H, Canudas S,et al.Circulating vitamin D levels and colorectal cancer risk: a Meta-analysis and systematic review of case-control and prospective cohort studies[J]. Crit Rev Food Sci Nutr, 2023,63:1-17.
[2] Chartron E, Firmin N, Touraine C,et al.A phase Ⅱ multicenter rial on high-dose vitamin D supplementation for the correction of vitamin D insufficiency in patients with breast cancer receiving adjuvant chemotherapy[J]. Nutrients, 2021,13:4429. doi: 10.3390/nu13124429.
[3] Pu Y, Zhu G, Xu Y, et al.Association between vitamin D exposure and head and neck cancer: a systematic review with Meta-analysis[J]. Front Immunol, 2021,12:627226. doi:10.3389/fimmu.2021.627226.
[4] Johansson H, Spadola G, Tosti G, et al. Vitamin D supplementation and disease-free survival in stage Ⅱ melanoma: a randomized placebo controlled trial. [J] Nutrients, 2021,13:1931. doi:10.3390/nu13061931.
[5] Zhang Y, Jiang X, Li X, et al.Serum vitamin D levels and risk of liver cancer: a systematic review and dose-response meta-analysis of cohort studies[J]. Nutr Cancer,2021,73:1-9.
[6] Wu J, Yang N, Yuan M. Dietary and circulating vitamin D and risk of renal cell carcinoma: a Meta-analysis of observational studies[J]. Int Braz J Urol,2021,47:733-744.
[7] Piatek K, Kutner A, Cacsire Castillo-Tong D, et al. Vitamin D analogs regulate the vitamin D system and cell viability in ovarian cancer cells[J]. Int J Mol Sci,2021,23:172. doi:10.3390/ijms23010172.
[8] Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an endocrine society clinical practice guideline. [J] Clin Endocrinol Metab, 2024,109:1907-1947.
[9] Kanno K, Akutsu T, Ohdaira H,et al. Effect of vitamin D supplements on relapse or death in a p53-immunoreactive subgroup with digestive tract cancer: post hoc analysis of the AMATERASU randomized clinical trial[J]. JAMA Netw Open, 2023,6:e2328886. doi:10.1001/jamanetworkopen.
[10] 王征,杨红,金梦,等.维生素D受体对低氧下结肠细胞屏障蛋白的作用[J]. 中国医学科学院学报,2019,41:506-511.
[11] Fernández-Barral A, Costales-Carrera A, Buira SP,et al.Vitamin D differentially regulates colon stem cells in patient-derived normal and tumor organoids[J]. FEBS J, 2020,287:53-72.
[12] Guo S, Zhao W, Zhang W,et al. Vitamin D promotes ferroptosis in colorectal cancer stem cells via SLC7A11 downregulation[J]. Oxid Med Cell Longev, 2023,2023:4772134. doi:10.1155/2023/4772134.
[13] Yu X, Wang Q, Liu B,et al. Vitamin D enhances radiosensitivity of colorectal cancer by reversing epithelial-mesenchymal transition[J]. Front Cell Dev Biol,2021,9:684855. doi:10.3389/fcell.2021.684855.
[14] Giampazolias E, Pereira da Costa M, Lam KC, et al. Vitamin D regulates microbiome-dependent cancer immunity. [J] Science, 2024,384:428-437. doi:10.1126/science.adh7954.
[15] EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, et al. Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate[J]. EFSA J, 2023,21:e08145. doi:10.2903/j.efsa.
[16] Morita M, Okuyama M, Akutsu T,et al. Vitamin D supplementation regulates postoperative serum levels of PD-L1 in patients with digestive tract cancer and improves survivals in the highest quintile of PD-L1: a post hoc analysis of the AMATERASU randomized controlled trial. [J] Nutrients, 2021,13:1987. doi:10.3390/nu13061987.
[17] Fujimoto H, Fukuzato S, Kanno K, et al. Reduced relapse-free survival in colorectal cancer patients with elevated soluble CD40 ligand levels improved by vitamin D supplementation[J]. Nutrients, 2023,15:4361. doi:10.3390/nu15204361.
[18] Bellerba F, Serrano D, Johansson H, et al. Colorectal cancer, vitamin D and microbiota: a double-blind phase Ⅱ randomized trial (ColoViD) in colorectal cancer patients[J]. Neoplasia,2022,34:100842. doi:10.1016/j.neo.2022.100842.
[19] Bader DA, Abed A, Mohammad BA, et al. The effect of weekly 50,000 IU vitamin D₃ supplements on the serum levels of selected cytokines involved in cytokine storm: a randomized clinical trial in adults with vitamin D deficiency[J]. Nutrients, 2023,15:1188. doi:10.3390/nu15051188.
[20] Srichomchey P, Sukprasert S, Khulasittijinda N,et al. Vitamin D₃ supplementation promotes regulatory T-cells to maintain immune homeostasis after surgery for early stages of colorectal cancer. [J] In Vivo, 2023,37:286-293.
[21] Lee SH, Park HK, Kang CD, et al. High dose intramuscular vitamin D₃ supplementation impacts the gut micro-biota of patients with clostridioides difficile infection[J]. Front Cell Infect Microbiol, 2022,12:904987. doi:10.3389/fcimb.2022.904987.